Nyrada Inc Sustainability Reports
Nyrada Inc. is a clinical-stage biotechnology company specializing in the discovery and development of innovative small-molecule therapies. The company focuses on developing drugs for cardiovascular and neurological diseases, targeting areas of substantial unmet clinical need.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
FIGI: BBG00QZ9DRQ2
9 reports from 2018 to 2026
